Tip: Try author name, DOI (10.xxxx/…), or keywords.

ISSN (Online): 1694-4674
  1. Home
  2. Vol. 05, No. 09, (2026)
  3. Magnetic Resonance Imaging Features of Malignant Soft Tissue Tumours: …
Case Series Open Access

Magnetic Resonance Imaging Features of Malignant Soft Tissue Tumours: Histopathological Correlation in 25 Cases

,,
Annals of Medicine and Medical SciencesVol. 05, No. 09, (2026) September 22, 2026pp. 2280 - 2287

Abstract

Objective: To evaluate the magnetic resonance imaging (MRI) features of malignant soft tissue tumours and to correlate these findings with histopathology. Design: Retrospective observational case series. Subjects: Twenty-five patients with histologically proven malignant soft tissue tumours who underwent MRI as the primary imaging modality. Methods: Each lesion was assessed for size, location, compartment, signal characteristics, presence of necrosis or haemorrhage, margins and fascial infiltration, enhancement pattern, and neurovascular involvement; imaging findings were correlated with histopathological diagnosis. Results: Soft tissue sarcoma not otherwise specified was the most common diagnosis (4 cases, 16%); synovial sarcoma, Kaposi sarcoma, clear cell sarcoma, and rhabdomyosarcoma each accounted for 3 cases (12%). Heterogeneous T2 hyperintensity was present in 85% of lesions, necrosis or haemorrhage in 70%, diffusion restriction in 80% of high-grade tumours, and heterogeneous post-contrast enhancement in 75%. Neurovascular involvement was identified in 6 cases (24%) and osseous infiltration in 3 (12%). Synovial sarcoma demonstrated the characteristic triple-signal pattern in 2 of 3 cases, and all clear cell sarcomas showed T1 hyperintensity consistent with melanocytic differentiation. Conclusion: MRI provides characteristic, reproducible imaging signatures for common histological subtypes of malignant soft tissue tumours and reliably delineates local extent, supporting close correlation with histopathology and pre-treatment staging.

Keywords

Sarcoma Soft Tissue Neoplasms Magnetic Resonance Imaging Diffusion Magnetic Resonance Imaging Synovial Sarcoma Rhabdomyosarcoma Neurofibroma Histopathology.

Introduction

Soft tissue sarcomas are an uncommon and heterogeneous group of malignant tumours of mesenchymal origin, with a reported incidence of approximately 4-8 per 100,000 in Western populations; their tendency toward local infiltration and delayed diagnosis contributes disproportionately to cancer-related morbidity [1]. The 2020 World Health Organization classification divides soft tissue sarcomas into more than a dozen broad categories comprising over 70 histological subtypes, each with distinct morphological, immunohistochemical, and molecular features [1,2].

Magnetic resonance imaging (MRI) is the imaging modality of choice for the local staging of soft tissue tumours because of its superior soft tissue contrast, multiplanar capability, and ability to characterise signal behaviour, enhancement pattern, and involvement of adjacent neurovascular and osseous structures [3,4]. While no single MRI feature is pathognomonic for malignancy, certain signal and enhancement patterns, when interpreted together with patient age, tumour location, and growth pattern, considerably narrow the differential diagnosis and help direct biopsy and surgical planning [5,6].

This study was undertaken to evaluate the spectrum of MRI features of histologically confirmed malignant soft tissue tumours encountered at our institution and to correlate these imaging findings with histopathology, with the aims of (a) describing the key MRI characteristics of malignant soft tissue tumours, (b) assessing staging features including neurovascular and osseous involvement, (c) correlating MRI findings with histopathological subtypes, and (d) identifying distinctive imaging features across this 25-case series.

Materials and Methods

This was a retrospective observational study of 25 patients with histologically proven malignant soft tissue tumours evaluated in the Department of Radiology. All patients underwent MRI as the primary imaging modality prior to biopsy or surgical excision, and the histopathological diagnosis obtained subsequently was used as the reference standard for confirmation of the imaging diagnosis.

MRI examinations were performed on a 1.5-T MRI system (Siemens Healthineers, Erlangen, Germany) using dedicated surface coils. Standard multiplanar T1-weighted, T2-weighted, short tau inversion recovery (STIR), diffusion-weighted, and post-contrast fat-suppressed T1-weighted sequences were acquired [7]. Intravenous gadolinium-based contrast material (0.1 mmol/kg) was administered when indicated.

Results

Of the 25 histologically confirmed malignant soft tissue tumours evaluated, soft tissue sarcoma not otherwise specified (NOS) was the most frequently encountered diagnosis (4 cases), followed by synovial sarcoma, Kaposi sarcoma, clear cell sarcoma, and rhabdomyosarcoma (3 cases each). Spindle cell sarcoma, neurofibroma, kaposiform haemangioendothelioma, and nerve sheath tumour accounted for 2 cases each, while metastatic deposits were identified in 1 case. The distribution of histological diagnoses is shown in Table 1 and Figure 1.

Table 1 Distribution of malignant soft tissue tumour cases by histological diagnosis (n = 25).
Diagnosis Number of cases
Soft tissue sarcoma (NOS) 4
Synovial sarcoma 3
Kaposi sarcoma 3
Spindle cell sarcoma 2
Clear cell sarcoma 3
Neurofibroma 2
Rhabdomyosarcoma 3
Kaposiform haemangioendothelioma 2
Nerve sheath tumour 2
Metastatic deposits 1
Total 25

Table footnote: NOS, not otherwise specified. Percentages of the total cohort (n = 25) are reported in the text and in Figure 1.

Figure 1
Figure 1 Distribution of malignant soft tissue tumour diagnoses in the study cohort (n = 25).

On qualitative review of the MRI findings across the cohort, heterogeneous T2 hyperintensity was the most common feature, present in 85% of cases. Necrosis or haemorrhage was identified in 70% of lesions, most frequently in soft tissue sarcoma, spindle cell sarcoma, and rhabdomyosarcoma. Restricted diffusion was noted in 80% of high-grade tumours. Heterogeneous post-contrast enhancement was seen in 75% of cases, whereas Kaposi sarcoma characteristically showed predominantly homogeneous enhancement. Neurovascular involvement was identified in 6 cases and osseous infiltration in 3 cases, both indicating locally advanced disease at presentation. Synovial sarcoma demonstrated the characteristic triple-signal pattern in 2 of 3 cases, and clear cell sarcoma showed T1 hyperintensity in all 3 of its cases, reflecting its melanocytic differentiation.

Discussion

The overall imaging–histopathology concordance in this series was high, particularly for synovial sarcoma, nerve sheath tumour, and clear cell sarcoma, in keeping with previously reported diagnostic performance of MRI for soft tissue sarcoma subtyping [5,6]. The individual case findings are summarised below.

Synovial sarcoma

A 28-year-old male presented with progressive swelling and pain in the posterior knee. MRI demonstrated a large lobulated soft-tissue mass in the right popliteal fossa and proximal leg with mixed T2/STIR signal, restricted diffusion, and heterogeneous enhancement. The mass involved the posterior compartment muscles, more prominently medially, and compressed and encased the popliteal vessels without definite loss of flow void, findings consistent with previously described appearances of synovial sarcoma, including the characteristic triple-signal pattern [8,9].

Figure 2
Figure 2 Synovial sarcoma. Axial MR images of the right popliteal fossa showing a lobulated mass with mixed signal intensity encasing the popliteal vessels.

Rhabdomyosarcoma

A 58-year-old female presented with rapidly progressive, painful swelling of the right leg. MRI showed a lobulated, infiltrative soft-tissue mass arising from muscle, hypointense on T1 and markedly hyperintense on T2/STIR with internal myxoid and necrotic areas. The lesion showed heterogeneous enhancement, restricted diffusion, ill-defined margins with intermuscular spread, neurovascular displacement and encasement, surrounding oedema, and probable regional lymphadenopathy, in keeping with previously described rhabdomyosarcoma imaging characteristics [10].

Figure 3
Figure 3 Rhabdomyosarcoma. MR images of the right leg showing an infiltrative, T2/STIR-hyperintense intramuscular mass with heterogeneous enhancement.

Nerve sheath tumour

A 52-year-old female presented with a gradually increasing left arm mass and associated discomfort. MRI of the proximal arm showed a well-defined, ovoid lesion within or adjacent to the biceps muscle compartment, T1 hypointense and T2/STIR hyperintense with thin internal septations and smooth margins, without surrounding muscle oedema or bone involvement; the neurovascular bundle was preserved.

Figure 4
Figure 4 Nerve sheath tumour. Well-defined T2/STIR-hyperintense ovoid lesion in the proximal arm with preserved neurovascular bundle.

Spindle cell sarcoma

A 45-year-old female presented with a painless, slowly enlarging swelling in the anterolateral forearm. MRI showed a well-defined, hyperintense soft-tissue lesion in the anterolateral forearm with a preserved muscle interface and a few internal flow voids, suggesting a neurogenic origin. The underlying bones were normal, the elbow joint showed minimal physiological effusion, neurovascular bundles were preserved, and no deep extension or bony involvement was seen.

Figure 5
Figure 5 Spindle cell sarcoma. Well-defined hyperintense forearm lesion with a preserved muscle interface and internal flow voids.

Soft tissue sarcoma

A 77-year-old male presented with a firm, enlarging medial thigh swelling. MRI showed a large, well-defined mass in the medial right thigh, involving the vastus intermedius and vastus medialis, with low T1 and heterogeneous high T2/proton-density signal, and heterogeneous post-contrast enhancement. No underlying bone involvement was seen.

Figure 6
Figure 6 Soft tissue sarcoma. Well-defined heterogeneous T2/proton-density-hyperintense mass in the medial thigh musculature.

Clear cell sarcoma

A 32-year-old female presented with a slowly enlarging, painful mass in the upper thigh. Imaging of the left proximal femur showed an infiltrative soft-tissue mass with periosteal and medullary extension, involving adjacent thigh muscles but sparing the major neurovascular bundles, with surrounding oedema and moderate post-contrast enhancement — findings suggestive of a malignant lesion, later confirmed as clear cell sarcoma. Reflecting its melanocytic differentiation, this tumour, like the other two cases in the series, showed T1 hyperintensity, consistent with previously reported imaging features of clear cell sarcoma [11].

Figure 7
Figure 7 Clear cell sarcoma. Infiltrative soft-tissue mass in the left proximal femur with periosteal and medullary extension.

Kaposiform haemangioendothelioma

A 10-year-old female presented with facial swelling and gradually increasing jaw fullness. MRI showed a large, ill-defined, infiltrative mass in the right masticator space extending into the infratemporal and submandibular spaces, with T2 hyperintensity and cystic/serpiginous areas, T1 dark-to-intermediate signal, and no major flow voids - features suggestive of an infiltrative vascular tumour and consistent with previously described imaging of kaposiform haemangioendothelioma [12].

Figure 8
Figure 8 Kaposiform haemangioendothelioma. Infiltrative T2-hyperintense mass in the right masticator space with serpiginous vascular areas.

Kaposi sarcoma

A 48-year-old male with a history of chronic lymphoedema presented with leg pain and swelling. MRI showed a fairly well-defined, T2/STIR-hyperintense and T1 iso- to hypointense, lobulated expansile lesion involving the distal third of the right fibula at the metadiaphyseal region, causing mild medullary expansion and patchy anterior cortical destruction. In keeping with the pattern observed across all three cases of Kaposi sarcoma in this series, enhancement was predominantly homogeneous, in contrast to the heterogeneous pattern seen in most other tumour subtypes, consistent with reported Kaposi sarcoma imaging patterns [13].

Figure 9
Figure 9 Kaposi sarcoma. Expansile T2/STIR-hyperintense lesion of the distal right fibula with cortical destruction.

Neurofibroma

A 26-year-old male presented with progressively worsening ankle pain and tingling along the plantar aspect of the foot. A lobulated, beaded lesion, T2/STIR hyperintense and showing restricted diffusion, was noted along the neurovascular bundle close to the posterior tibial vessels, extending from the ankle to the plantar aspect of the foot and dividing at the level of the midfoot — a distribution and morphology characteristic of a peripheral nerve sheath origin.

Figure 10
Figure 10 Neurofibroma. Beaded, T2/STIR-hyperintense lesion tracking along the posterior tibial neurovascular bundle.

Metastatic deposits

A patient with known carcinoma of the urinary bladder, with nodal and skeletal metastases following chemotherapy and immunotherapy, presented with swelling in the right shoulder. MRI showed T1-hypointense marrow lesions in the proximal humeral shaft and scapula with STIR hyperintensity and a hair-on-end periosteal reaction, in keeping with metastatic deposits. Lobulated, T1-low/T2-high intramuscular collections were also noted in the deltoid with surrounding intra- and intermuscular oedema, favoured to represent post-radiation change.

Figure 11
Figure 11 Metastatic deposits. Marrow and intramuscular lesions of the right shoulder with periosteal reaction, in a patient with known urothelial carcinoma.

Across the series, benign nerve sheath tumours (schwannoma/ neurofibroma) demonstrated well-defined margins, a target sign, and homogeneous or mildly heterogeneous enhancement, distinguishing them from malignant peripheral nerve sheath tumours (MPNST), which characteristically showed loss of the target sign and ill-defined margins, correlating with malignant transformation [14,15]. These findings are consistent with recent literature describing MRI features that differentiate benign from malignant soft-tissue tumours, including margin definition, degree of T2 heterogeneity, and the presence of necrosis, as reproducible discriminators of grade [16-18]. Standardised whole-body staging protocols proposed by the European Society of Musculoskeletal Radiology emphasise systematic assessment of compartmental involvement and neurovascular proximity, both of which were key discriminating features in this series, particularly in cases with locally advanced disease such as the synovial sarcoma and clear cell sarcoma cases described above [19,20].

Limitations

Limitations of this study include its retrospective, single-centre design and the relatively small sample size, which precludes formal statistical analysis of diagnostic accuracy; larger multicentre cohorts, ideally incorporating radiomic and multiparametric analysis, would help validate the imaging–histopathological associations identified here [2,21-24].

Conclusion

In conclusion, a total of 25 malignant soft tissue tumours were evaluated on MRI and confirmed by histopathology. Heterogeneous T2 hyperintensity, necrosis or haemorrhage, restricted diffusion, and heterogeneous enhancement were the most frequent imaging findings. MRI demonstrated strong concordance with histopathology and remains a valuable modality for tumour characterisation, local staging, and pre-operative planning.

Key Messages

  • MRI reliably differentiates histological subtypes of malignant soft tissue tumours based on characteristic signal, enhancement, and diffusion patterns.

  • Heterogeneous T2 hyperintensity, necrosis/haemorrhage, and restricted diffusion are frequent features of high-grade malignant tumours in this cohort.

  • Synovial sarcoma and clear cell sarcoma demonstrate distinctive imaging signatures (triple-signal pattern and T1 hyperintensity, respectively) that aid diagnosis.

  • MRI accurately delineates neurovascular and osseous involvement, supporting its central role in pre-treatment staging and surgical planning.

Declarations

Conflict of interest

The authors have no conflicts of interest to declare.

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Ethical Approval

This retrospective study was conducted in accordance with the ethical guidelines of the institution, including adherence to the legal requirements of the study country. The study was approved by the institutional review board / research ethics committee, and the requirement for individual patient consent was waived given the retrospective, de-identified nature of the analysis.

Author Contribution

Sai Keerthana Sarabudla: Conceptualisation, data collection, image analysis, and drafting of the manuscript.

N. L. N. Moorthy: Study supervision, critical review of imaging findings, and critical revision of the manuscript for important intellectual content.

Padmaja Singireddy: Data analysis, histopathological correlation, and critical revision of the manuscript. All authors read and approved the final manuscript.

Declaration of Human Rights

The authors confirm that they accept and agree with the United Nations' Declaration of Human Rights.

References

  1. WHO Classification of Tumours Editorial Board. Soft Tissue and Bone Tumours. 5th ed. Lyon: International Agency for Research on Cancer; 2020. Google Scholar ↗
  2. Doyle LA. Sarcoma classification: an update based on the 2013 World Health Organization Classification of Tumors of Soft Tissue and Bone. Cancer. 2014;120(12):1763–1774. DOI: DOI ↗ Google Scholar ↗
  3. Noebauer-Huhmann IM, Vanhoenacker FM, Vilanova JC, et al. Soft tissue tumors in adults: ESSR-approved guidelines for diagnostic imaging. Semin Musculoskelet Radiol. 2015;19(5):475–482. DOI: DOI ↗ Google Scholar ↗
  4. Van Rijswijk CS, Geirnaerdt MJ, Hogendoorn PC, et al. Soft-tissue tumors: value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy. Radiology. 2004;233(2):493–502. DOI: DOI ↗ Google Scholar ↗
  5. Kransdorf MJ, Murphey MD. Imaging of Soft Tissue Tumors. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2006. Google Scholar ↗
  6. Noebauer-Huhmann IM, Vanhoenacker FM, Vilanova JC, et al. Soft tissue tumor imaging in adults: European Society of Musculoskeletal Radiology Guidelines 2023 — overview, and primary local imaging: how and where? Eur Radiol. 2024;34(7):4427–4437. DOI: DOI ↗ Google Scholar ↗
  7. Berquist TH. MRI of Orthopedic and Sports Injuries. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2012. Google Scholar ↗
  8. Murphey MD, Gibson MS, Jennings BT, Crespo-Rodriguez AM, Fanburg-Smith J, Gajewski DA. Imaging of synovial sarcoma with radiologic-pathologic correlation. Radiographics. 2006;26(5):1543–1565. DOI: DOI ↗ Google Scholar ↗
  9. O'Sullivan PJ, Harris AC, Munk PL. Radiological features of synovial cell sarcoma. Br J Radiol. 2008;81(964):346–356. DOI: DOI ↗ Google Scholar ↗
  10. Parham DM, Ellison DA. Rhabdomyosarcomas in adults and children: an update. Arch Pathol Lab Med. 2006;130(10):1454–1465. DOI: DOI ↗ Google Scholar ↗
  11. Hocar O, Le Cesne A, Berissi S, et al. Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 52 cases. Dermatol Res Pract. 2012;2012:984096. DOI: DOI ↗ Google Scholar ↗
  12. Restrepo CS, Martínez S, Lemos JA, Carrillo JA, Lemos DF, Ojeda P, Koshy P. Imaging manifestations of Kaposi sarcoma. Radiographics. 2006;26(4):1169–1185. DOI: DOI ↗ Google Scholar ↗
  13. Ji Y, Chen S, Yang K, Xia C, Li L. Kaposiform haemangioendothelioma: current knowledge and future perspectives. Orphanet J Rare Dis. 2020;15:39. DOI: DOI ↗ Google Scholar ↗
  14. Wasa J, Nishida Y, Tsukushi S, Shido Y, Sugiura H, Nakashima H, Ishiguro N. MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas. AJR Am J Roentgenol. 2010;194(6):1568–1574. DOI: DOI ↗ Google Scholar ↗
  15. Wilson MP, Katlariwala P, Low G, Murad MH, McInnes MDF, Jacques L, Jack AS. Diagnostic accuracy of MRI for the detection of malignant peripheral nerve sheath tumors: a systematic review and meta-analysis. AJR Am J Roentgenol. 2021;217(1):31–39. DOI: DOI ↗ Google Scholar ↗
  16. Crombé A, Marcellin PJ, Buy X, Stoeckle E, Brouste V, Italiano A, Le Loarer F, Kind M. Soft-tissue sarcomas: assessment of MRI features correlating with histologic grade and patient outcome. Radiology. 2019;291(3):710–721. DOI: DOI ↗ Google Scholar ↗
  17. Fayad LM, Jacobs MA, Wang X, Carrino JA, Bluemke DA. Musculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniques. Radiology. 2012;265(2):340–356. DOI: DOI ↗ Google Scholar ↗
  18. Gielen JLMA, De Schepper AM, Vanhoenacker F, Parizel PM, Wang XL, Sciot R, Weyler J. Accuracy of MRI in characterization of soft tissue tumors and tumor-like lesions: a prospective study in 548 patients. Eur Radiol. 2004;14(12):2320–2330. DOI: DOI ↗ Google Scholar ↗
  19. Noebauer-Huhmann IM, Vanhoenacker FM, Vilanova JC, et al. Whole-body staging in sarcoma and non-malignant soft tissue tumors: ESSR Guidelines 2024. Eur Radiol. 2024;35(1):351–359. DOI: DOI ↗ Google Scholar ↗
  20. De Schepper AM, Vanhoenacker F, Gielen J, Parizel PM. Imaging of Soft Tissue Tumors. 4th ed. Berlin: Springer; 2017. Google Scholar ↗
  21. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, eds. WHO Classification of Tumours of Soft Tissue and Bone. 4th ed. Lyon: IARC Press; 2013. Google Scholar ↗
  22. Vallières M, Freeman CR, Skamene SR, El Naqa I. A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities. Phys Med Biol. 2015;60(14):5471–5496. DOI: DOI ↗ Google Scholar ↗
  23. Jagannathan JP, Tirumani SH, Ramaiya NH. Imaging in soft tissue sarcomas: current updates and future directions. Surg Oncol Clin N Am. 2016;25(4):645–675. DOI: DOI ↗ Google Scholar ↗
  24. Baheti AD, O'Malley RB, Kim S, Keraliya AR, Tirumani SH, Ramaiya NH, Wang CL. Soft-tissue sarcomas: an update for radiologists based on the revised 2013 World Health Organization classification. AJR Am J Roentgenol. 2016;206(5):924–932. DOI: DOI ↗ Google Scholar ↗